文献速递冠心病心力衰竭与心肌病

冠状动脉微血管疾病:发病机制与治疗选择——JACC最新综述

Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

本文综述冠状动脉微血管疾病(CMD)的病理生理机制、诊断策略及治疗选择,指出多数CMD患者合并大血管动脉粥样硬化,并将CMD按严重程度及是否合并动脉粥样硬化分为不同表型,强调CMD在肥胖、胰岛素抵抗、射血分数保留的心力衰竭及非阻塞性/阻塞性冠心病中的意义,并探讨其作为新干预靶点的前景。

要点

  • CMD影响冠状动脉微循环结构与功能,与不良事件风险增加相关。
  • 多数CMD患者合并大血管动脉粥样硬化,影响预后与管理。
  • CMD按严重程度及是否合并动脉粥样硬化分为不同表型。

核心结论

  • CMD是影响冠状动脉微循环结构与功能的疾病,与不良事件风险增加相关,且多数患者合并大血管动脉粥样硬化。

研究设计与样本

  • 本文为JACC最新综述,总结CMD的病理生理、诊断测试更新及表型分类,并探讨特定人群中的意义和新型干预靶点。

主要发现

  • CMD在广泛心血管危险因素患者中普遍存在,并与不良事件风险增加相关。
  • 多数CMD患者合并大血管动脉粥样硬化,对预后和管理有重要影响。
  • CMD在肥胖和胰岛素抵抗、心肌损伤和射血分数保留的心力衰竭、非阻塞性和阻塞性冠状动脉疾病等特定人群中具有重要意义。

临床怎么用

  • 临床应关注CMD在广泛心血管危险因素患者中的存在,并评估是否合并大血管动脉粥样硬化以指导管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Coronary microvascular disease (CMD) refers to the subset of disorders affecting the structure and function of the coronary microcirculation, is prevalent in patients across a broad spectrum of cardiovascular risk factors, and is associated with an increased risk of adverse events. Contemporary evidence supports that most patients with CMD also have macrovessel atherosclerosis, which has important implications for their prognosis and management. In this state-of-the-art review, the authors summarize the pathophysiology of CMD, provide an update of diagnostic testing strategies, and classify CMD into phenotypes according to severity and coexistence with atherosclerosis. They examine emerging data highlighting the significance of CMD in specific populations, including obesity and insulin resistance, myocardial injury and heart failure with preserved ejection fraction, and nonobstructive and obstructive coronary artery disease. Finally, they discuss the role of CMD as a potential target for novel interventions beyond conventional approaches, representing a new frontier in cardiovascular disease reduction.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Taqueti VR, Di Carli MF. Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018. PMID: 30466521. doi:10.1016/j.jacc.2018.09.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。